Hormone replacement therapy with estradiol and drospirenone: An overview of the clinical data

@article{Whitehead2006HormoneRT,
  title={Hormone replacement therapy with estradiol and drospirenone: An overview of the clinical data},
  author={M. Whitehead},
  journal={Post Reproductive Health},
  year={2006},
  volume={12},
  pages={4 - 7}
}
A new form of continuous combined hormone replacement therapy has become available that contains estradiol and drospirenone as the progestogen component. Drospirenone is a synthetic progestogen, the only one in hormone replacement therapy in the UK that possesses clinically relevant anti-mineralocorticoid activity. The combination of estradiol and drospirenone has been shown to provide relief from estrogen-deficiency symptoms of the menopause. It also helps to prevent osteoporosis in… Expand

References

SHOWING 1-10 OF 10 REFERENCES
Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
  • A. Rübig
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2003
Hormone therapy: the European women's perspective
New progestogens: a review of their effects in perimenopausal and postmenopausal women
  • Drugs Aging
  • 2004
symptoms in postmenopausal women : a double - blind , randomized , placebo - controlled study of the safety and efficacy of three dose regimens
  • 2004
Angeliq summary of product characteristics . June 2005 2
    Angeliq summary of product characteristics . June 2005 2